HLB Therapeutics is advancing towards becoming a sustainable enterprise for the future through the establishment of diverse business areas.

As a company specializing in new drug clinical development, HLB Therapeutics possesses a forward-looking approach to finding competitive pipelines and a differentiated infrastructure capable of driving global drug commercialization.

We have the expertise to directly manage global clinical trial organizations and manufacturing service organizations through our skilled and active personnel.

HLB Therapeutics' business model focuses on enhancing the company’s value and realizing investor returns through licensing deals with multinational pharmaceutical companies upon development completion. Furthermore, as a new drug development company, we strive to contribute to patients suffering from unmet medical needs by developing innovative therapies.

Although global clinical trials come with many challenges, HLB Therapeutics is committed to leveraging its specialized competitive advantages to become a leading new drug development company in the global market in the near future.

Thank you.

CEO Ki-hong Ahn